In the US, Dolasetron (dolasetron systemic) is a member of the drug class 5HT3 receptor antagonists and is used to treat Nausea/Vomiting - Chemotherapy Induced and Nausea/Vomiting - Postoperative.
US matches:
- Dolasetron
- Dolasetron Tablets
- Dolasetron Oral, Intravenous
- Dolasetron Mesylate
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
A04AA04
CAS registry number (Chemical Abstracts Service)
0115956-12-2
Chemical Formula
C19-H20-N2-O3
Molecular Weight
324
Therapeutic Categories
Antiemetic
Serotonin antagonist
Chemical Name
1H-Indole-3-carboxylic acid, octahydro-3-oxo-2,6-methano-2H-quinolizin-8-yl ester, (2α,6α,8α,9aß)-
Foreign Names
- Dolasetronum (Latin)
- Dolasetron (German)
- Dolasétron (French)
- Dolasetron (Spanish)
Generic Names
- Dolasetron (OS: BAN)
- Dolasétron (OS: DCF)
- Dolasetron Mesilate (OS: BANM)
- Dolasetron Mesylate (OS: USAN)
- MDL 73147 EF (IS)
- Dolasetron Mesylate (PH: USP 32)
- Dolasetron Mesylate (OS: USAN)
Brand Names
- Anzemet
Sanofi-Aventis, Switzerland; Sanofi-Aventis, United States - Anemet
Sanofi-Aventis, Germany - Anzemet
Aventis, Luxembourg; Aventis, Tunisia; Hoechst, Poland; Lepetit, Romania; Patheon, Romania; Sanofi-Aventis, Australia; Sanofi-Aventis, Brazil; Sanofi-Aventis, Canada; Sanofi-Aventis, France; Sanofi-Aventis, Greece; Sanofi-Aventis, Italy; Sanofi-Aventis, Malta; Sanofi-Aventis, Mexico; Sanofi-Aventis, United States; Sanofi-Aventis, Venezuela - Zamanon
Aventis, South Africa
International Drug Name Search
Glossary
BAN | British Approved Name |
BANM | British Approved Name (Modified) |
DCF | Dénomination Commune Française |
IS | Inofficial Synonym |
OS | Official Synonym |
PH | Pharmacopoeia Name |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment